DHIVY was designed with your unique needs in mind

2 doctors developed DHIVY using a patented technology

Image does not represent the actual size of the tablet.

DHIVY is functionally scored, so it’s made to be broken
With deep grooves, DHIVY was designed to break evenly and cleanly
Firm enough not to break accidentally

DHIVY provides daily carbidopa/
levodopa (CD/LD) dosing flexibility at your fingertips

DHIVY can be taken whole or in segments

Take DHIVY as prescribed by your doctor.

If you need a whole tablet of DHIVY:

Swallow the tablet whole. If you have trouble swallowing a whole tablet, you can snap DHIVY into segments.

Drawing of 2 hands holding a DHIVY tablet

Image does not represent the actual size of the tablet.

If you need to snap DHIVY into segments:

Ensure you are holding the tablet in both hands, then gently push downward on each side of the tablet’s groove.

Watch the video to learn more about how to snap a DHIVY tablet.

DHIVY is a CD/LD tablet designed to be divided

In one snappable tablet, DHIVY provides a range of segments.

Divide your daily dose to fit your day

1 whole tablet

(25 mg/100 mg)

3/4 tablet

(18.75 mg/75 mg)

1/2 tablet

(12.5 mg/50 mg)

1/4 tablet

(6.25 mg/25 mg)

1/4 of DHIVY is the smallest segment available within a 25 mg/100 mg CD/LD tablet

Images do not represent the actual size of the tablet.

See if you’re eligible to save on DHIVY.

Get started

Tips on how to take DHIVY

If breaking DHIVY for a segmented dose, place the remainder of the tablet somewhere safe for later use.

Take DHIVY with or without food.

Store DHIVY at room temperature in a tightly closed container that’s protected from light and moisture.

Talk to your doctor before making any adjustments to your medications.

DHIVY has similar side effects to
other forms of CD/LD. See side effects

Stay up to date on DHIVY

Get exclusive access to resources and tips to
help you throughout your time on DHIVY.

Image does not represent the actual size of the tablet.

IMPORTANT SAFETY INFORMATION

DHIVY is contraindicated in patients

Currently taking a nonselective monoamine oxidase (MAO) inhibitor (e.g., phenelzine, linezolid, and tranylcypromine) or have recently (within 2 weeks) taken a nonselective MAO inhibitor. Hypertension can occur if these drugs are used concurrently.
With known hypersensitivity to any component of DHIVY.

Taking DHIVY may result in falling asleep while engaged in normal activities, even without warning and as late as 1 year or later after starting DHIVY. This may affect your ability to drive or operate machinery, resulting in accidents. Do not do anything that requires alertness until you know how DHIVY affects you. Tell your healthcare provider about any sleep medicines you take or if you have a sleep disorder, and discuss any episodes of drowsiness or sleepiness you experience while taking DHIVY.

Talk to your healthcare provider before you change the dose or stop taking DHIVY, as this may result in serious side effects. Call your healthcare provider immediately if you develop withdrawal symptoms such as fever, confusion, or severe muscle stiffness.

Tell your healthcare provider if you have any heart conditions, especially if you have had a heart attack or irregular heartbeats. Your heart function should be monitored during the time period your DHIVY dose is first adjusted.

Treatment with DHIVY may cause hallucinations or abnormal thoughts and behaviors. Be sure to tell your healthcare provider if you experience excessive suspicion; seeing, hearing, or feeling things that are not real; confusion; agitation; aggressive behavior; and disorganized thinking.

Treatment with DHIVY may also cause intense urges to gamble, increased sexual urges, intense urges to spend money, binge eating, and other intense urges, as well as the inability to control those urges. Uncontrolled sudden movements of the face, arms, legs, or trunk may appear or get worse during treatment with DHIVY. This may mean your dosage of DHIVY or other Parkinson’s medications needs to be adjusted.

Tell your healthcare provider if you have ever had a peptic ulcer or glaucoma, as treatment with DHIVY may worsen these conditions. DHIVY also may cause abnormal blood or urine test results.

Some patients taking DHIVY may experience depression or suicidal thoughts. Tell your healthcare provider if you have thoughts of suicide.

The most common side effects that may appear with DHIVY include uncontrolled sudden movements and nausea.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using DHIVY with certain other medicines, including MAO inhibitors, isoniazid, iron supplements, medicines for high blood pressure or those that increase or decrease dopamine levels, or metoclopramide, may cause serious side effects.

Notify your healthcare provider if you become pregnant or intend to become pregnant during DHIVY therapy or if you intend to breastfeed or are breastfeeding an infant.

Please see full Prescribing Information.

INDICATION

DHIVY is a prescription medication that contains a combination of carbidopa and levodopa for the treatment of Parkinson’s disease, Parkinson’s disease caused by infection or inflammation of the brain, or Parkinson’s disease–like symptoms that may result from carbon monoxide or manganese poisoning.